Total Revenue (USD, thousands)

Cost of Goods Sold (COGS) (USD, thousands)

SG&A (USD, thousands)

R&D (USD, thousands)

D&A (USD, thousands)

Interest Expense (USD, thousands)

Operating Income (EBIT) (USD, thousands)

Net Income (USD, thousands)

EPS - Basic (USD)

EPS - Diluted (USD)

a55ad93760e28dd13d7bda94074818006120f1cf6742ca530270c328f45ead75

Adjustments for Non-Cash Items (USD, thousands)

Stock-Based Compensation (USD, thousands)

Changes in Working Capital (USD, thousands)

Capital Expenditures (CapEx) (USD, thousands)

Proceeds from / Repayments of Debt (USD, thousands)

Share Repurchases (USD, thousands)

Dividend Payments (USD, thousands)

Net Change in Cash (USD, thousands)

59b35f92602e1dc5973dd8380f9e5c7d2b1c9b2a7d48852a9f345f2193f16c58

Current Assets (USD, thousands)

Cash and Cash Equivalents (USD, thousands)

Accounts Receivable (USD, thousands)

Inventory (USD, thousands)

Non-Current Assets (USD, thousands)

Property, Plant, and Equipment (PP&E) (USD, thousands)

Goodwill (USD, thousands)

Intangible Assets (USD, thousands)

Current Liabilities (USD, thousands)

Accounts Payable (USD, thousands)

Short-term Debt (USD, thousands)

Accrued Expenses (USD, thousands)

Non-Current Liabilities (USD, thousands)

Long-term Debt (USD, thousands)

Lease Liabilities (USD, thousands)

Deferred Tax Liabilities (USD, thousands)

Shareholders' Equity (USD, thousands)

Retained Earnings (USD, thousands)

Common Stock (USD, thousands)

Additional Paid-in Capital (USD, thousands)

732916f3c58b1353ebd6a014a199232b0532378d6017291a68e35ecd07ef2372

Net income (loss)

Depreciation and amortization

Stock-based compensation expense

Loss (income) from equity method investments

(Gain) loss on sale of assets, net

Other noncash items

Changes in operating assets and liabilities

Net cash provided by (used in) operating activities

Purchase of property and equipment

Purchase of intangible assets

Investment in loans receivable and other

Investments in marketable securities

Proceeds from maturities and sales of marketable securities and other

Net cash provided by (used in) investing activities

Proceeds from equity issuances, net

Repayments of long-term debt

Net cash provided by (used in) financing activities

Net increase (decrease) in cash, cash equivalents and restricted cash and equivalents

Cash, cash equivalents and restricted cash and equivalents, beginning of period

Cash, cash equivalents and restricted cash and equivalents, end of period

cb5bd613144f2441874eecb87d8c292b7611ba53d3c20e9b74c9305337dd9240

Medical services revenue (USD, thousands)

Other operating revenue (USD, thousands)

Total revenues (USD, thousands)

Medical services expense (USD, thousands)

Other medical expenses (USD, thousands)

General and administrative (USD, thousands)

Depreciation and amortization (USD, thousands)

Total expenses (USD, thousands)

Income (loss) from operations (USD, thousands)

Income (loss) from equity method investments (USD, thousands)

Other income (expense), net (USD, thousands)

Interest expense (USD, thousands)

Income (loss) before income taxes (USD, thousands)

Income tax benefit (expense) (USD, thousands)

Income (loss) from continuing operations (USD, thousands)

Income (loss) before gain (loss) on sales (Discontinued Operations) (USD, thousands)

Adjustments on sale of assets, net (Discontinued Operations) (USD, thousands)

Total discontinued operations (USD, thousands)

Net income (loss) (USD, thousands)

Noncontrolling interests’ share in (earnings) loss (USD, thousands)

Net income (loss) attributable to common shares (USD, thousands)

Net income (loss) per common share, basic and diluted: Continuing operations (USD)

Net income (loss) per common share, basic and diluted: Discontinued operations (USD)

Weighted average shares outstanding, basic and diluted (shares, thousands)

c899025ab2210c31a09ec9269e57f30233f601e9551b9bd6bf40731676c3ebf8

Cash and cash equivalents (USD, thousands)

Restricted cash and equivalents (USD, thousands)

Receivables, net (USD, thousands)

Prepaid expenses and other current assets, net (USD, thousands)

Total current assets (USD, thousands)

Property and equipment, net (USD, thousands)

Intangible assets, net (USD, thousands)

Other assets (USD, thousands)

Total assets (USD, thousands)

Medical claims and related payables (USD, thousands)

Accounts payable and accrued expenses (USD, thousands)

Current portion of long-term debt (USD, thousands)

Total current liabilities (USD, thousands)

Long-term debt, net of current portion (USD, thousands)

Other liabilities (USD, thousands)

Total liabilities (USD, thousands)

Common stock, $0.01 par value (USD, thousands)

Additional paid-in capital (USD, thousands)

Accumulated deficit (USD, thousands)

Total agilon health, inc. stockholders' equity (deficit) (USD, thousands)

Noncontrolling interests (USD, thousands)

Total stockholders’ equity (deficit) (USD, thousands)

Total liabilities and stockholders’ equity (deficit) (USD, thousands)

6c4908406fa9bb886ac772e7bb391d063e753207bf3db6e4f5472a63ccdd3c9d

Medical Services Revenue

Other Operating Revenue

Total Revenue

3cce2fe254ef8f136b76c866b4e0d878072de27c1d6eb7e134b29caad200ddc9

agilon health inc (AGL)

Financials